Cancer-related fatigue in breast cancer survivors: A longitudinal analysis compared to matched controls.
AnnaLynn M. Williams(University of Rochester), Michelle C. Janelsins(University of Rochester), Debra L. Barton(University of Michigan), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Lora Weiselberg(Seagen (Canada)), Carly L. Paterson(National Cancer Institute), Kelley Lynn Young(Seagen (Canada)), Alison Conlin(Providence Portland Medical Center), Luke J. Peppone(University of Rochester Medical Center)
Cited by 3
Related Papers
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
|Journal of Clinical Oncology|2020|556
Applied Discriminant Analysis
|Technometrics|1995|409